← Eichor
Study identifier: NCT05136703 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)

Condition: Depression · HIV-1-infection · Inflammation  ·  Sponsor: Florida International University

PhaseNA
Planned participants150
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this randomized controlled trial is to understand how a cognitive-behavioral treatment (a form of psychological treatment) for depression changes the gut microbiome (micro-organisms that regulate the health of the gut), immune system, and the brain functioning in people living with HIV.

This description comes directly from the study's public registry record.

Talk to the study team

Adam W Carrico, PhD  ·  (305) 348-7887  ·  acarrico@fiu.edu

Always discuss trial participation with your own doctor first.

Locations (2)

University of Miami Neuroimaging FacilityCoral Gables, Florida, United StatesRecruiting
Care Resource - Midtown MiamiMiami, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05136703